1813001

Ruutiainen K

1991

Polycystic ovary syndrome: evolution of a concept.

1814652

Balen AH

1991

Gonadotrophin surge attenuating factor: a missing link in the control of LH secretion?

1814658

Bennet A

1991

Correlations between mean LH levels and LH pulse characteristics: differences between normal and anovulatory women.

1823293

Baldissera SF

1991

Proposal of an experimental model for the study of polycystic ovaries.

1825605

Kovacs G

1991

Treatment of anovulation due to polycystic ovarian syndrome by laparoscopic ovarian electrocautery.

1825813

Elkind-Hirsch KE

1991

Androgen responses to acutely increased endogenous insulin levels in hyperandrogenic and normal cycling women.

1827032

Fox R

1991

Oestrogen and androgen states in oligo-amenorrhoeic women with polycystic ovaries.

1827700

Byrne B

1991

Sex steroids, adiposity and smoking in the pathogenesis of idiopathic hirsutism and polycystic ovary syndrome.

1827701

Ponjee GA

1991

Androstanediolglucuronide: a parameter for peripheral androgen activity before and during therapy with cyproterone acetate.

1828239

Buffington CK

1991

Opposing actions of dehydroepiandrosterone and testosterone on insulin sensitivity. In vivo and in vitro studies of hyperandrogenic females.

1829956

Giagulli VA

1991

Is plasma 5 alpha-androstane 3 alpha, 17 beta-diol glucuronide a biochemical marker of hirsutism in women?

1830013

Kitabchi AE

1991

Role of adrenal and gonadal androgens in insulin action and metabolism.

1832519

Gonzalez F

1991

Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome.

1833937

Baron JJ

1991

[Endocrine and ultrasound examination of hirsutism].

1834923

Eden JA

1991

The polycystic ovary syndrome presenting as resistant acne successfully treated with cyproterone acetate.

1835936

G?rgan T

1991

Evaluation of adhesion formation after laparoscopic treatment of polycystic ovarian disease.

1835937

Buyalos RP

1991

No acute effect of physiological insulin increase on dehydroepiandrosterone sulfate in women with obesity and/or polycystic ovarian disease.

1837781

Weise HC

1991

[Results of treatment with surface cauterization of polycystic ovaries in sterility patients].

1837783

Lehmann F

1991

[Ovarian pregnancy after gamete transfer (gift). A case report].

1837973

Puziga?a Z

1991

Ovarian enlargement as a possible marker of androgen activity in polycystic ovary syndrome.

1838735

Rudelstorfer B

1991

[Wound closure with fibrin glue in pelviscopic surgery].

1838876

V?tr M

1991

Metoclopramide test in women with PCO syndrome after ovarian wedge resection.

1839616

Bunker CB

1991

The hormonal profile of women with acne and polycystic ovaries.

1839885

Semm K

1991

Pelviscopy.

1839945

Strizhakov AN

1991

[Surgical laparoscopy in gynecology].

1844618

Devoto L

1991

[Effect of microsurgical resection of the ovary on fertility in patients with polycystic ovary resistant to clomiphene citrate].

1847963

Ding YQ

1991

Discordant levels of serum bioactive LH in man as measured in different in-vitro bioassay systems using rat and mouse interstitial cells and human granulosa-luteal cells.

1853507

Sanders RC

1991

Infertility diagnosis by ultrasound.

1862846

Pamfamirov IuK

1991

[Current aspects of the diagnosis of the sclerocystic ovary syndrome].

1862856

Kuznetsova IV

1991

[Hyperplastic processes in the target organs of women over 35 who have undergone an operation for the wedge resection of polycystic ovaries].

1872121

Invitti C

1991

Increased urinary free cortisol and decreased serum corticosteroid-binding globulin in polycystic ovary syndrome.

1872336

Nader S

1991

Polycystic ovary syndrome and the androgen-insulin connection.

1874935

Dunaif A

1991

Acanthosis Nigricans, insulin action, and hyperandrogenism: clinical, histological, and biochemical findings.

1894042

Chapdelaine PA Jr

1991

Bulimia and polycystic ovarian syndrome?

1898744

Nestler JE

1991

A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome.

1898891

Sagle MA

1991

A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndrome.

1898892

Remorgida V

1991

Use of combined exogenous gonadotropins and pulsatile gonadotropin-releasing hormone in patients with polycystic ovarian disease.

1898893

Mizunuma H

1991

The role of endogenous gonadotropin release in the etiology of ovarian enlargement during purified urinary follicle-stimulating hormone therapy.

1898894

Mais V

1991

Adjusting the dose to the individual response of the patient during the induction of ovulation with pulsatile gonadotropin-releasing hormone.

1900490

Yuen BH

1991

Pulsatile administration of human menopausal gonadotropins.

1900742

Vermes I

1991

Interpretations of five monoclonal immunoassays of lutropin and follitropin: effects of normalization with WHO standard.

1901089

Kupferminc MJ

1991

Ovulation induction with gonadotropins in women with polycystic ovary disease.

1901280

Aboulghar MA

1991

Improvement of spontaneous pregnancy rate after stopping gonadotropin therapy for anovulatory infertility.

1902487

Filicori M

1991

Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.

1902845

Christman GM

1991

Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease.

1903681

Rossmanith WG

1991

The impact of ovarian laser surgery on the gonadotrophin secretion in women with polycystic ovarian disease.

1903724

Meldrum DR

1991

Low dose follicle-stimulating hormone therapy for polycystic ovarian disease.

1903725

Shoham Z

1991

Polycystic ovarian syndrome: safety and effectiveness of stepwise and low-dose administration of purified follicle-stimulating hormone.

1903726

Anttila L

1991

Clinical features and circulating gonadotropin, insulin, and androgen interactions in women with polycystic ovarian disease.

1903734

Mizunuma H

1991

Ovulation induction by step-down administration of purified urinary follicle-stimulating hormone in patients with polycystic ovarian syndrome.

1905311

Neyro JL

1991

Pure FSH for ovulation induction in patients with polycystic ovary syndrome and resistant to clomiphene citrate therapy.

1905314

Dale PO

1991

In-vitro fertilization in infertile women with the polycystic ovarian syndrome.

1905833

Buvat J

1991

[Contribution of pure FSH in ovulation induction excluding fertilization in vitro].

1906896

van Weissenbruch MM

1991

Evidence for existence of immunoglobulins that block ovarian granulosa cell growth in vitro. A putative role in resistant ovary syndrome?

1907938

Steck T

1991

[Continuous pulsatile subcutaneous gonadotropin stimulation in polycystic ovary syndrome: a therapeutic alternative].

1909705

Fauser BC

1991

Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.

1910247

Ginsburg J

1991

Ovulation induction with human menopausal gonadotropins--a changing scene.

1915936

Levin JH

1991

Is the inappropriate gonadotropin secretion of patients with polycystic ovary syndrome similar to that of patients with adult-onset congenital adrenal hyperplasia?

1916652

Velardo A

1991

Evidence of altered dopaminergic modulation of prolactin and thyrotropin secretion in patients with polycystic ovary syndrome.

1916689

Lonsdale RN

1991

Autoimmune oophoritis associated with polycystic ovaries.

1918298

Emperaire JC

1991

Triggering ovulation with endogenous luteinizing hormone may prevent the ovarian hyperstimulation syndrome.

1918302

Owen EJ

1991

Co-treatment with growth hormone of sub-optimal responders in IVF-ET.

1919182

Yoshino K

1991

[Changes in serum androgen levels in patients with polycystic ovary syndrome].

1924408

Lee MT

1991

Circulating hormone concentrations in hypothyroid rats with induced polycystic ovaries.

1925369

Gompel A

1991

[Secondary amenorrhea. Diagnostic orientation].

1927084

Lindecken KD

1991

[Pedicle torsion, hemorrhagic ovarian infarct. A rare cause of pediatric acute abdomen].

1927298

Ding YQ

1991

Neither exogenous nor endogenous GnRH stimulation alters the bio/immuno ratio of serum LH in healthy women and in polycystic ovarian disease.

1929195

Lorcy Y

1991

[Induction of ovulation by pulsatile gonadoliberin administration. Indications and limits].

1934157

Lachelin GG

1991

The polycystic ovary syndrome.

1935128

Caruso A

1991

Induction of ovulation with gonadotropins in patients with polycystic ovarian syndrome.

1936315

Shoham Z

1991

Is it possible to run a successful ovulation induction program based solely on ultrasound monitoring? The importance of endometrial measurements.

1936318

Takai I

1991

Three types of polycystic ovarian syndrome in relation to androgenic function.

1936493

Dahlgren E

1991

Endometrial carcinoma; ovarian dysfunction--a risk factor in young women.

1939548

Ingerslev HJ

1991

Selective follicular reduction following ovulation induction by exogenous gonadotrophins in polycystic ovarian disease. A new approach to treatment.

1940062

Slowi?ska-Srzednicka J

1991

The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome.

1951277

Gammon MD

1991

Polycystic ovaries and the risk of breast cancer.

1951959

Alieva EA

1991

[Infertility caused by the polycystic ovary syndrome].

1954173

Franks S

1991

The role of nutrition and insulin in the regulation of sex hormone binding globulin.

1955538

Ding YQ

1991

Preponderance of basic isoforms of serum luteinizing hormone (LH) is associated with the high bio/immune ratio of LH in healthy women and in women with polycystic ovarian disease.

1955660

Drapier-Faure E

1991

[Purified FSH in small doses. Is this not the best current treatment of polycystic ovaries resistant to clomid? 73 cycles].

1958541

Franks S

1991

Polycystic ovary syndrome: interaction of follicle stimulating hormone and polypeptide growth factors in oestradiol production by human granulosa cells.

1958579

Pugeat M

1991

Pathophysiology of sex hormone binding globulin (SHBG): relation to insulin.

1959509

Herzog AG

1991

Reproductive endocrine considerations and hormonal therapy for women with epilepsy.

1962361

Pache TD

1991

Transvaginal sonography and abnormal ovarian appearance in menstrual cycle disturbances.

1964216

Semicheva TV

1990

[The possible sources of hyperandrogenism in hirsutism in girls].

1964538

Carmina E

1990

Pituitary-adrenal responses to ovine corticotropin-releasing factor in polycystic ovary syndrome and in other hyperandrogenic patients.

1966195

Slizovski? GV

1990

[Ovarian polycystosis in a strangulated inguinal hernia in a newborn infant].

1968168

Stewart PM

1990

5 alpha-reductase activity in polycystic ovary syndrome.

1968442

Yoshino K

1990

Changes in plasma catecholamines and pulsatile patterns of gonadotropin release in subjects with a normal ovulatory cycle and with polycystic ovary syndrome.

1973920

Levran D

1990

Glucose tolerance in pregnant women following treatment for sterility.

1976930

Prelevi? GM

1990

Inhibitory effect of sandostatin on secretion of luteinising hormone and ovarian steroids in polycystic ovary syndrome.

1977716

Anapliotou MG

1990

Adrenal hyperresponsiveness to ACTH stimulation in women with polycystic ovary syndrome: an adrenarchal type of response.

1991526

McCluskey S

1991

Polycystic ovary syndrome and bulimia.

1995381

Abyholm T

1991

The first attempt at IVF treatment. Results and requirements for a satisfactory success rate.

2005928

Bonuccelli U

1991

Domperidone-induced acute dystonia and polycystic ovary syndrome.

2006808

Creasy GW

1991

Pulsatile delivery systems.

2010114

Takahashi K

1991

Endocrinological meaning of hyperandrogenism in patients with polycystic ovary.

2015337

Rojansky N

1991

Hirsutism in chronic psychiatric patients.

2021568

Abdel Gadir A

1991

Polycystic ovaries: do these represent a specific endocrinopathy?

2022063

Fox R

1991

The diagnosis of polycystic ovaries in women with oligo-amenorrhoea: predictive power of endocrine tests.